Natera

Natera NTRA Stock

$401.37   -2.905320%
Add to favorites
Market Cap
$57.86B
LOW - HIGH [24H]
$383.76 - $416.00
VOLUME [24H]
$1.61M
P/E Ratio
0
Earnings per share
-$1.35
ISIN
US6323071042
Price   Prediction

Natera Price Chart

Sorry, that's all we've gotfor now...

Natera NTRA Financial and Trading Overview

Natera stock price 401.37 USD
Previous Close 405.92 USD
Open 404.84 USD
Bid 383.68 USD x 100
Ask 449.96 USD x 100
Day's Range 404.84 - 420.15 USD
52 Week Range 181 - 437.41 USD
Volume 1.29M USD
Avg. Volume 1.47M USD
Market Cap 59.59B USD
Beta (5Y Monthly) 1.499
PE Ratio (TTM) N/A
EPS (TTM) -1.35 USD
Forward Dividend & Yield N/A (0%)
Ex-Dividend Date N/A
1y Target Est 409.57 USD

NTRA Valuation Measures

Enterprise Value 58.73B USD
Trailing P/E N/A
Forward P/E -1794.4956
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 22.01132
Price/Book (mrq) 32.593235
Enterprise Value/Revenue 21.696
Enterprise Value/EBITDA -261.71

Trading Information

Natera Stock Price History

Beta (5Y Monthly) 1.499
52-Week Change 111.98%
S&P500 52-Week Change 15.78%
52 Week High 437.41 USD
52 Week Low 181 USD
50-Day Moving Average 363.4 USD
200-Day Moving Average 260.11 USD

NTRA Share Statistics

Avg. Volume (3 month) 1.47M USD
Avg. Daily Volume (10-Days) 1.3M USD
Shares Outstanding 144.14M
Float 140.13M
Short Ratio 4.14
% Held by Insiders 2.73%
% Held by Institutions 96.63%
Shares Short 6.36M
Short % of Float 4.54%
Short % of Shares Outstanding 4.40%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio N/A
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) June 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin -7.10%
Operating Margin (ttm) -10.29%
Gross Margin 65.23%
EBITDA Margin -8.29%

Management Effectiveness

Return on Assets (ttm) -8.076%
Return on Equity (ttm) -12.54%

Income Statement

Revenue (ttm) 2.71B USD
Revenue Per Share (ttm) 19.32 USD
Quarterly Revenue Growth (yoy) 37.70%
Gross Profit (ttm) 1.77B USD
EBITDA -224420992 USD
Net Income Avi to Common (ttm) -192346000 USD
Diluted EPS (ttm) -1.35
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 1.09B USD
Total Cash Per Share (mrq) 7.57 USD
Total Debt (mrq) 238.49M USD
Total Debt/Equity (mrq) 13.09 USD
Current Ratio (mrq) 2.999
Book Value Per Share (mrq) 12.683

Cash Flow Statement

Operating Cash Flow (ttm) 228.24M USD
Levered Free Cash Flow (ttm) 104.03M USD

Profile of Natera

Country United States
State TX
City Austin
Address 13011 McCallen Pass
ZIP 78753
Phone 650 980 9190
Website https://www.natera.com
Industry Diagnostics & Research
Sector(s) Healthcare
Full Time Employees 6135

Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide. It offers Signatera, a personalized ctDNA blood test for MRD assessment, early recurrence monitoring, and evaluation of treatment response in patients previously diagnosed with cancer; Latitude, a blood-based MRD test for colorectal cancer; Altera, a tissue based comprehensive genomic profiling test; and Empower, a hereditary cancer screening test. The company also provides Panorama, a non-invasive prenatal test; Horizon, a carrier screening test; Fetal Focus, a single-gene NIPT, or sgNIPT, that screens for 21 single-gene inherited conditions; and Vistara, a single-gene NIPT, which screens for 25 single-gene conditions. In addition, it offers Anora, which tests and analyzes miscarriage tissue from women who have experienced one or more pregnancy losses; Empower, a hereditary cancer screening test; Prospera, a test to assess active rejection in patients who have undergone solid organ transplantation; Renasight, a kidney gene panel test; and Constellation software, a cloud-based distribution model. Further, the company provides NateraCore, a platform to support the patient and provider experience; phlebotomy services; and EMR integration services. The company serves independent laboratories, national and regional reference laboratories, medical centers and physician practices for its screening tests, research laboratories, and pharmaceutical companies through its direct sales force and laboratory distribution partners, as well as Constellation licensees under its cloud-based distribution model. It has a partnership agreement with BGI Genomics Co., Ltd. to develop, manufacture, and commercialize NGS-based genetic testing assays for clinical and commercial use. The company has a collaboration with Diakonos Oncology Corp. to assess molecular response in patients with refractory melanoma. The company was formerly known as Gene Security Network, LLC and changed its name to Natera, Inc. in January 2012. Natera, Inc. was founded in 2003 and is headquartered in Austin, Texas.

Q&A For Natera Stock

What is a current NTRA stock price?

Natera NTRA stock price today per share is 401.37 USD.

How to purchase Natera stock?

You can buy NTRA shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Natera?

The stock symbol or ticker of Natera is NTRA.

Which industry does the Natera company belong to?

The Natera industry is Diagnostics & Research.

How many shares does Natera have in circulation?

The max supply of Natera shares is 144.14M.

What is Natera Price to Earnings Ratio (PE Ratio)?

Natera PE Ratio is now.

What was Natera earnings per share over the trailing 12 months (TTM)?

Natera EPS is -1.35 USD over the trailing 12 months.

Which sector does the Natera company belong to?

The Natera sector is Healthcare.

Natera NTRA included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.symbol }} {{ item.name }} {{ item.symbol }} {{ item.country.toUpperCase() }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
us US Tech Composite IXIC US 26008.86 USD —
-2.6
7.83B USD — 25918.09 USD — 26359.41 USD — — 7.83B USD —
us US Tech Global Select Market Com NQGS US 12809.17 USD —
-2.61
— — 12764.75 USD — 12983.56 USD — — — —
us US Tech DM Ex Japan Large Mid Ca NQDMXJPLMAUD US 2100.38 AUD 1467.26 USD
<0.01
— — 2100.38 AUD 1467.26 USD 2100.38 AUD 1467.26 USD — — —
us US Tech Health Care IXHC US 1340.89 USD —
-0.01
— — 1326.18 USD — 1351.47 USD — — — —
us US Tech Composite Total Return XCMP US 32130.04 USD —
-2.6
— — 32017.91 USD — 32563.09 USD — — — —
us US Tech AlphaDEX Multi Cap Growt NQDXUSMLTCG US 3781.71 USD —
-2.06
— — 3758.99 USD — 3821.82 USD — — — —
$2.72T
Total marketcap
$68.83B
Total volume
BTC 60.02%   •   ETH 10.70%
Dominance
Select currency